A DAY WITH THE JUDGES
National Mid-Year Conference Co-Sponsored by the ACLM and WILM
Professional Ethics, Marijuana (Cannabis) and Opioid Crisis
Up to 12 Hours CME; 7 Hours CLE
Friday, October 23, 2020, Oklahoma City, Oklahoma
Course Fee $350.00
10% Discount ($315.000) for Early Bird Seminar Registration
Opioid Materials and Drug Courts
TO REGISTER: Please go to HOME page, and click on the button REGISTER NOW.
In case of problems, email your name, address and telephone number. Will be register and bill.
Opioids - General Topics
Preventing Opioid Overdose and Death
Drug Courts Materials
Medications for Opioid Use Disorder Save Lives (2019)
National Academies of Sciences, Engineering, and Medicine 2019. Washington, DC: The National Academies Press.
Summary of Conclusions
Opioid use disorder is a treatable chronic brain disease.
U.S. Food and Drug Administration (FDA)-approved medications to treat opioid use disorder are effective and save lives.
Long-term retention on medications to treat opioid use disorder is associated wit improved outcomes.
A lack of availability of behavioral interventions is not a sufficient justification to
withhold medications to treat opioid use disorder.
Most people who could benefit from medication-based treatment for opioid use disorder do not receive it, and access is inequitable across subgroups of the population.
Medication-based treatment is effective across all treatment settings studied to date. Withholding or failing to have available all classes of FDA-approved medication for the treatment of opioid use disorder in any care or criminal justice setting is denying appropriate medical treatment.
Confronting the major barriers to the use of medications to treat opioid use disorder is critical to addressing the opioid crisis.